Michael F. Salvatore
Department of Pharmacology,
Toxicology,
& Neuroscience,
Department of Pharmacology, Toxicology, & Neuroscience
louisiana state university health sciences center
Michael F. Salvatore has not added Biography.
If you are Michael F. Salvatore and would like to personalize this page please email our Author Liaison for assistance.
Decreased plasma membrane expression of striatal dopamine transporter in aging.
Neurobiology of aging Dec, 2003 | Pubmed ID: 14643386
Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Journal of neurochemistry Jul, 2004 | Pubmed ID: 15198683
Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
Brain research. Molecular brain research Oct, 2005 | Pubmed ID: 16051392
Bilateral effects of unilateral intrastriatal GDNF on locomotor-excited and nonlocomotor-related striatal neurons in aged F344 rats.
Neurobiology of aging Jan, 2007 | Pubmed ID: 16314001
Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum.
Neurobiology of aging Nov, 2007 | Pubmed ID: 16959378
Point source concentration of GDNF may explain failure of phase II clinical trial.
Experimental neurology Dec, 2006 | Pubmed ID: 16962582
Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia.
The Journal of neuropsychiatry and clinical neurosciences , 2007 | Pubmed ID: 17308229
Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.
The European journal of neuroscience Apr, 2008 | Pubmed ID: 18380664
Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
Experimental neurology Sep, 2009 | Pubmed ID: 19460370
Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation.
PloS one , 2009 | Pubmed ID: 20037632
GFR α-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways.
Journal of neurochemistry Nov, 2010 | Pubmed ID: 20731758
Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat.
Psychopharmacology Jun, 2011 | Pubmed ID: 21523347
Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Neurobiology of disease Mar, 2012 | Pubmed ID: 22198503
Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.
PloS one , 2012 | Pubmed ID: 22242182
Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19).
Experimental neurology Apr, 2012 | Pubmed ID: 22285253
Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit.
Synapse (New York, N.Y.) May, 2013 | Pubmed ID: 23280858
Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
PloS one , 2012 | Pubmed ID: 23300642
Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.
Molecular neurobiology Jun, 2013 | Pubmed ID: 23321789
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.
Molecular neurobiology Jun, 2014 | Pubmed ID: 24297323
ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
Journal of neurochemistry May, 2014 | Pubmed ID: 24410633
Peripheral and cognitive signs: delineating the significance of impaired catecholamine metabolism in Parkinson's disease progression.
Journal of neurochemistry Jul, 2014 | Pubmed ID: 25039428
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유